Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
Title:
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
Author:
Magro, Fernando Afonso, Joana Lopes, Susana Coelho, Rosa Gonçalves, Raquel Caldeira, Paulo Lago, Paula de Sousa, Helena Tavares Ramos, Jaime Gonçalves, Ana Rita Ministro, Paula Rosa, Isadora Vieira, Ana Isabel Andrade, Patrícia Soares, João-Bruno Carvalho, Diana Sousa, Paula Meira, Tânia Lopes, Joanne Moleiro, Joana Dias, Cláudia Camila Falcão, Amílcar Geboes, Karel Carneiro, Fatima